Hepatitis C in deceased drug addicts

Area of Science:

• Infectious Diseases
• Hepatology
• Public Health

Background:

• Needle sharing among drug users facilitates infectious disease transmission, including hepatitis B and AIDS.
• Hepatitis C virus (HCV) infection is a significant concern, with drug addicts identified as a key reservoir.
• The development of gene technology-based tests for HCV has improved diagnostic capabilities.

Purpose of the Study:

• To determine the prevalence of antibodies against HCV (anti-HCV) in deceased drug addicts in Hamburg.
• To investigate the age-specific prevalence of anti-HCV in this population.
• To examine co-infections with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) among HCV-positive individuals.

Main Methods:

• Retrospective analysis of blood samples from deceased drug addicts in Hamburg (1988-1990).
• Serological testing for antibodies against HCV (anti-HCV).
• Testing for antibodies to HBV (anti-HBc) and HIV in relevant subgroups.

Main Results:

• Antibodies against HCV (anti-HCV) were detected in 113 (40.1%) of 282 deceased drug addicts.
• The highest prevalence of anti-HCV was observed in the 30-34 year age group.
• Co-infections were noted: 59.4% of anti-HBc positive individuals were also anti-HCV positive, and 34.8% of HIV-infected individuals were anti-HCV positive.

Conclusions:

• Drug addicts represent a substantial reservoir for HCV infection.
• Age is a factor in HCV prevalence among drug users, with younger adults showing higher rates.
• High rates of co-infection with HBV and HIV highlight the complex infectious disease burden in this population.